T18	Exp 154 173	the etiologic agent
T19	Exp 290 292	it
T20	Exp 205 222	the viral protein
T21	Exp 252 267	the development
T22	Exp 271 282	the disease
T23	Exp 371 373	We
T24	Exp 383 393	the effect
T25	Exp 413 423	the growth
T26	Exp 427 444	the interleukin-2
T27	Exp 639 686	the cyclic AMP-responsive element-like sequence
T28	Exp 690 709	the HTLV-1 promoter
T29	Exp 779 783	that
T30	Exp 711 722	The finding
T31	Exp 784 805	the NF-kappaB pathway
T32	Exp 870 885	the CRE pathway
T33	Exp 750 768	these two pathways
T34	Exp 912 925	both pathways
T35	Exp 1032 1043	Our results
T36	Exp 1225 1274	its well-known IL-2-dependent cell transformation
T37	Exp 1049 1053	that
T38	Exp 1119 1123	that
R3	Coref Anaphora:T19 Antecedent:T21
R4	Coref Anaphora:T36 Antecedent:T39
T1	Protein 35 38	tax
T2	Protein 57 70	interleukin-2
T3	Protein 200 203	Tax
T4	Protein 397 400	Tax
T5	Protein 431 444	interleukin-2
T6	Protein 446 450	IL-2
T7	Protein 503 506	Tax
T8	Protein 552 556	IL-2
T9	Protein 570 574	IL-2
T10	Protein 588 591	Tax
T11	Protein 726 729	Tax
T12	Protein 824 828	IL-2
T13	Protein 1027 1030	Tax
T14	Protein 1054 1057	Tax
T15	Protein 1124 1127	Tax
T16	Protein 1152 1156	IL-2
T17	Protein 1240 1244	IL-2
T39	Exp 1213 1221	addition
